Press release
Peptide Therapeutics Market Poised for 9.6% CAGR Growth Through 2031, Fueled by Advanced Drug Delivery Technologies | TMR Study
Peptide Therapeutics Market
Preview crucial insights and findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=418
Market Size and Growth
The peptide therapeutics market was valued at US$ 37.8 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 9.6% from 2023 to 2031. By the end of 2031, the market is expected to surpass US$ 85.9 billion, driven by rising demand for targeted therapies, increased funding for peptide-based drug development, and the growing burden of chronic illnesses worldwide. The rise of innovative peptide-based therapeutic vaccines is another factor contributing to the robust expansion of this market.
Competitive Landscape
The peptide therapeutics industry is characterized by intense competition among key players striving to enhance their market presence through strategic collaborations, product innovations, and mergers & acquisitions. Major companies such as Amgen, Inc., Eli Lilly and Company, Novartis AG, Pfizer, Inc., Sanofi, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd. are investing heavily in R&D to develop next-generation peptide drugs. The increasing focus on in-house manufacturing and outsourcing to contract manufacturing organizations (CMOs) also plays a significant role in shaping market dynamics.
Market Segmentation
The peptide therapeutics market is segmented based on various factors, including product type, application, peptide type, and manufacturing type:
• By Product Type: Innovative peptides dominate the market due to high investment in R&D and a strong pipeline of novel peptide drugs.
• By Application: The metabolic segment held the largest market share in 2022, fueled by the rising prevalence of diabetes, obesity, osteoarthritis, and osteoporosis.
• By Peptide Type: Native peptides emerged as the leading category, as they offer improved safety, efficacy, and tolerability compared to synthetic alternatives.
• By Manufacturing Type: The in-house segment led the market in 2022 due to cost-effectiveness, greater control over production processes, and flexibility in drug development.
Visit our report to explore critical insights and analysis - https://www.transparencymarketresearch.com/peptide-therapeutics-market.html
Regional Analysis
North America dominated the peptide therapeutics market in 2022, owing to the presence of key pharmaceutical companies and strong investments in drug development. The region's high prevalence of chronic diseases, along with favorable regulatory frameworks, supports market growth.
Asia Pacific is projected to witness significant growth in the coming years due to the rising burden of diabetes and cancer in countries such as China, India, and Japan. The region's expanding healthcare infrastructure and increasing adoption of advanced peptide-based therapies contribute to this upward trend.
Future Outlook
The future of the peptide therapeutics market looks promising, with continuous advancements in drug discovery and development. The growing interest in peptide-based vaccines, coupled with breakthroughs in nanoparticle-formulated peptide solutions and AI-driven drug discovery platforms, is expected to revolutionize the market. Regulatory developments, such as the FDA's 2023 draft guidance on peptide drug products, will play a crucial role in shaping market trends by setting new standards for clinical pharmacology and labeling.
Key Developments
• September 2023: The FDA issued draft guidance on clinical pharmacology and labeling for peptide drug products, focusing on immunogenicity risk assessment and pharmacokinetics.
• June 2023: Asep Medical received a US$ 200,000 grant for developing a nanoparticle-formulated peptide solution to treat chronic sinus infections.
• March 2023: Fujitsu launched its "Biodrug Design Accelerator" platform to support peptide drug discovery research, enhancing the design and testing of peptide drug candidates.
Buy this Premium Research Report and unlock critical data and findings - https://www.transparencymarketresearch.com/checkout.php?rep_id=418<ype=S
More Trending Reports by Transparency Market Research -
Prosthetic Disc Nucleus Market - https://www.transparencymarketresearch.com/prosthetic-disc-nucleus-pdn-market.html
Cystatin C Assay Market - https://www.transparencymarketresearch.com/cystatin-c-assay-market.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Therapeutics Market Poised for 9.6% CAGR Growth Through 2031, Fueled by Advanced Drug Delivery Technologies | TMR Study here
News-ID: 3886690 • Views: …
More Releases from Transparency Market Research
Global SiC Ceramics Market Poised for Robust Growth, Projected to Reach USD 3.1 …
The global silicon carbide (SiC) ceramics market continues to demonstrate strong growth potential, underpinned by accelerating demand from advanced industrial and electronic applications. Valued at US$ 1.8 Billion in 2024, the market is projected to reach US$ 3.1 Billion by 2035, expanding at a compound annual growth rate (CAGR) of 5.2% during the forecast period from 2025 to 2035. This steady expansion reflects the increasing importance of SiC ceramics as…
Furfuryl Alcohol Market to Reach USD 1.34 Billion by 2035, Supported by Rising D …
The global Furfuryl Alcohol Market was valued at US$ 624.3 million in 2024 and is projected to reach US$ 1,341.2 million by 2035, expanding at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2035.
This growth is primarily driven by the rising demand for bio-based and sustainable chemicals, along with the steady expansion of the foundry and metal casting industry, particularly across emerging economies in Asia Pacific.
Gain a…
Air-Entraining Agents Market Outlook 2035: Forecast to Reach US$ 2.48 Billion by …
The global Air-Entraining Agents (AEAs) Market was valued at US$ 1.70 billion in 2024 and is projected to reach US$ 2.48 billion by 2035, expanding at a compound annual growth rate (CAGR) of 3.5% from 2025 to 2035. This steady growth trajectory reflects the essential role AEAs play in modern concrete formulations, particularly in infrastructure projects that demand long-term durability, freeze-thaw resistance, and improved workability.
Despite being a mature segment within…
A2P SMS Market Outlook 2035: Expanding from US$ 71.2 Bn in 2024 to US$ 117.0 Bn …
The global Application-to-Person (A2P) SMS market is entering a phase of steady and resilient expansion, driven by the growing need for secure, reliable, and real-time communication between enterprises and consumers. Valued at US$ 71.2 Bn in 2024, the market is projected to reach US$ 117.0 Bn by 2035, expanding at a CAGR of 4.2% from 2025 to 2035. Despite the rise of internet-based messaging platforms, A2P SMS continues to maintain…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
